Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 Candler Dr
Ste 300
Savannah, GA 31405Phone+1 912-354-6187Fax+1 912-355-0596
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1999 - 2002
- Emory University School of MedicineResidency, Internal Medicine, 1996 - 1999
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996
Certifications & Licensure
- GA State Medical License 1998 - 2025
- SC State Medical License 2002 - 2025
- NC State Medical License 1999 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 159 citationsCombination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen
Journal of Clinical Oncology. 2023-01-10 - 8 citationsE3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination With High-Dose Interferon-α2b in Advanced MelanomaAhmad A. Tarhini, Sandra J. Lee, Xiaoxue Li, Uma N. M. Rao, Arun Nagarajan
Clinical Cancer Research. 2019-01-15
Press Mentions
- With This Grant Renewal Comes New Initiatives and Grant Aims to Further Expand Cancer Research to a Broader Population and Include Underserved Populations in Cancer Research:July 16th, 2019
- Savannah Doctor Extols Immunotherapy Drugs in Cancer TreatmentsOctober 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: